Arthroscopic Synovectomy Combined With DMARDs in the Treatment of Refractory Elbow Rheumatoid Arthritis

Rheumatoid Arthritis of Ankle Clinical Trial

Official title: Arthroscopic Synovectomy Combined With DMARDs in the Treatment of Refractory Elbow Rheumatoid Arthritis

Status Enrolling by invitation

Clinical Trial Summary

Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic and aggressive polyarthritis. The prevalence of RA in China is about 0.42%. Arthroscopic synovectomy (AS) is an important method to save the function of joint in the treatment of refractory RA. The clinical trial is to study the value of AS combine with DMARDs in the early stage of refractory RA.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Arthritis
• Arthritis, Rheumatoid
• Rheumatoid Arthritis of Ankle

• NCT number: NCT04454034
• Study type: Observational
• Source: Peking University Third Hospital
• Status: Enrolling by invitation
• Start date: August 1, 2019
• Completion date: December 31, 2021